Please login to the form below

Not currently logged in
Email:
Password:

KP360 launches tool for medical affairs

Healthcare communications agency KnowledgePoint360 Group has introduced the tool suite Lumina to support the needs of medical affairs teams in the US

Healthcare communications agency KnowledgePoint360 Group has introduced Lumina, a suite of targeted medical communications and strategic services to support the needs of medical affairs teams within the pharmaceutical industry in the US.

The Lumina suite of services support medical affairs organisations to inform, develop, and execute strategic medical plans.

Elements include: strategic planning, thought leader profiling, strategy workshops, competitive intelligence, scientific content development, clinical education support, protocol development, knowledge documents, clinical trial landscape analysis, advisory boards, and digital communication solutions.

These services have been tailored to to meet the needs of medical directors, medical science liaisons, clinical operations, medical information, and scientific publications teams.

Dr Joseph Kohles, a former international medical leader for Roche, said: "The medical affairs organisations in pharmaceutical and biotechnology companies play a critical role in addressing the information needs of healthcare professionals and patients. They have also been faced with an ever increasing number of responsibilities over the past several years, often without sufficient resources to ensure their success."

Dr Greg Thompson, senior vice president and medical director at KP360, said: "KnowledgePoint360 divisions have a long history of exceptional support for medical affairs organisations, and with the introduction of Lumina, we offer resources that address their many strategic and tactical objectives."

26th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics